[1] PIMPIN L,CORTEZ-PINTO H,NEGRO F,et al. Burden of liver disease in Europe:Epidemiology and analysis of risk factors to identify prevention policies[J]. J Hepatol,2018,69(3):718-735.
|
[2] BLEI AT. Portal hypertension and its complications[J]. Gastroenterology,2010,45(Suppl 1):1715-1728.
|
[3] SPIGOS DG,JONASSON O,MOZES M. Partial splenic embolization in the treatment of hypersplenism[J]. AJR Am J Roentgenol,1979,132(5):777-782.
|
[4] DUBOIS B,MOBLEY D,CHICK JFB,et al. Efficacy and safety of partial splenic embolization for hypersplenism in preand post-liver transplant patients:A 16-year comparative analysis[J]. Clin imaging,2019,54:71-77.
|
[5] ZHU K,MENG X,QIAN J,et al. Partial splenic embolization for hypersplenism in cirrhosis:A long-term outcome in 62 patients[J]. Dig Liver Dis,2009,41(6):411-416.
|
[6] YOSHIDA H,MAMADA Y,TANIAI N,et al. Partial splenic embolization[J]. Hepatol Res,2010,38(3):225-233.
|
[7] MARTINS GLP,BERNARDES JPG,ROVELLA MS,et al. Radiofrequency ablation for treatment of hypersplenism:A feasible therapeutic option[J]. World J Gastroenterol,2015,21(20):6391-6397.
|
[8] XIANG WJ,FEI G,YAN M,et al. Percutaneous microwave ablation in the spleen for treatment of hypersplenism in cirrhosis patients[J]. Dig Dis Sci,2016,61(1):287-292.
|
[9] LIU Q,MA K,SONG Y,et al. Two-year follow-up of splenic radiofrequency ablation in patients with cirrhotic hypersplenism:Does increased hepatic arterial flow induce liver regeneration?[J]. Surgery,2008,143(4):509-518.
|
[10] ZHOU RZ,XIE FP,CHEN L. Analysis on risk factors of patients with upper gastrointestinal bleeding in cirrhosis[J]. J Clin Exp Med,2019,18(12):1280-1283.(in Chinese)周仁正,谢发平,陈璐.肝硬化合并上消化道出血患者的危险因素分析[J].临床和实验医学杂志,2019,18(12):1280-1283.
|
[11] KALVA SP,SALAZAR GM,WALKER TG. Transjugular intrahepatic portosystemic shunt for acute variceal hemorrhage[J].Tech Vasc Interv Radiol,2009,12(2):92-101.
|
[12] DING ZF,YIN SW. Application of Viatorr covered stent in transjugular intrahepatic portosystemic shunt[J]. J Clin Hepatol,2018,34(5):1107-1110.(in Chinese)丁智锋,殷世武. Viatorr覆膜支架在经颈静脉肝内门体分流术中的应用现状[J].临床肝胆病杂志,2018,34(5):1107-1110.
|
[13] Chinese Medical Association Digestive Diseases Branch Digestive Intervention Group. Consensus on transjugular intrahepatic portosystemic shunt for treatment of cirrhotic portal hypertension[J]. J Clin Hepatol,2014,30(3):210-213.(in Chinese)中华医学会消化病学分会消化介入学组.经颈静脉肝内门体静脉分流术治疗肝硬化门静脉高压共识意见[J].临床肝胆病杂志,2014,30(3):210-213.
|
[14] WARD TJ,TECHASITH T,LOUIE JD,et al. Emergent salvage direct intrahepatic portocaval shunt procedure for acute variceal hemorrhage[J]. J Vasc Interv Radiol,2015,26(6):829-834.
|
[15] IMAI Y,NAKAZAWA M,ANDO S,et al. Long-term outcome of 154 patients receiving balloon-occluded retrograde transvenous obliteration for gastric fundal varices[J]. J Gastroenterol Hepatol,2016,31(11):1844-1850.
|
[16] JANG SY,KIM GH,PARK SY,et al. Clinical outcomes of balloon-occluded retrograde transvenous obliteration for the treatment of gastric variceal hemorrhage in Korean patients with liver cirrhosis:a retrospective multicenter study[J]. Clin Mol Hepatol,2012,18(4):368-374.
|
[17] GIMM G,CHANG Y,KIM HC,et al. Balloon-occluded retrograde transvenous obliteration versus transjugular intrahepatic portosystemic shunt for the management of gastric variceal bleeding[J]. Gut Liver,2018,12(6):704-713.
|
[18] WANG YB,ZHANG JY,GONG JP,et al. Balloon-occluded retrograde transvenous obliteration versus transjugular intrahepatic portosystemic shunt for treatment of gastric varices due to portal hypertension:A meta-analysis[J]. J Gastroenterol Hepatol,2016,31(4):727-733.
|
[19] BENGMARK S,BRJESSON B,HOEVELS J,et al. Obliteration of eso PHTageal varices by PTP:A follow-up of 43 patients[J]. Ann Surg,1979,190(4):549-554.
|
[20] TIAN X,WANG Q,ZHANG C,et al. Modified percutaneous transhepatic variceal embolization with 2-octylcyanoacrylate for bleeding gastric varices:Long-term follow-up outcomes[J]. AJR Am J Roentgenol,2011,197(2):502-509.
|
[21] SAAD WEA,LIPPERT A,AAD NE,et al. Ectopic varices:anatomical classification,hemodynamic classification,and hemodynamic-based management[J]. Tech Vasc Interv Radiol,2013,16(2):108-125.
|
[22] HOUSE T,WEBB P,BAARSON C. Massive hemorrhage from ectopic duodenal varices:Importance of a multidisciplinary approach[J]. Case Rep Gastroenterol,2017,11(1):36-41.
|
[23] CHOI JW,KIM HC,JAE HJ,et al. Transcatheter embolotherapy with N-Butyl cyanoacrylate for ectopic varices[J]. Cardiovasc Intervent Radiol,2015,38(2):344-351.
|
[24] SATO T. Treatment of ectopic varices with portal hypertension[J]. World J Hepatol,2015,7(12):1601-1605.
|
[25] ZHAO R,LU J,SHI Y,et al. Current management of refractory ascites in patients with cirrhosis[J]. J Int Med Res,2018,46(3):1138-1145.
|
[26] Chinese Society of Hepatology,Chinese Medical Association.Guidelines on the management of ascites and complications in cirrhosis[J]. J Clin Hepatol,2017,33(10):1847-1863.(in Chinese)中华医学会肝病学分会.肝硬化腹水及相关并发症的诊疗指南[J].临床肝胆病杂志,2017,33(10):1847-1863.
|
[27] LUNGREN MP,KIM CY,STEWART JK,et al. Tunneled peritoneal drainage catheter placement for refractory ascites:Single-center experience in 188 patients[J]. J Vasc Interv Radiol,2013,24(9):1303-1308.
|
[28] PICCIRILLO M,RINALDI L,LEONGITO M,et al. Percutaneous implant of Denver peritoneo-venous shunt for treatment of refractory ascites:A single center retrospective study[J].Eur Rev Med Pharmacol Sci,2017,21(21):3668-3673.
|
[29] KIM MY,CHOI H,BAIK SK,et al. Portal hypertensive gastropathy:Correlation with portal hypertension and prognosis in cirrhosis[J]. Dig Dis Sci,2010,55(12):3561-3567.
|
[30] SALEEM K,BAIG FA,NIDA M,et al. Correlation between severity of portal hypertensive gastropathy and size of OesoPHTageal varices in cirrhotic hepatitis-C patients[J]. J Ayub Med Coll Abbottabad,2018,30(1):54-57.
|
[31] GARG H,GUPTA S,ANAND AC,et al. Portal hypertensive gastropathy and gastric antral vascular ectasia[J]. Indian J Gastroenterol,2015,34(5):351-358.
|
[32] SNYDER P,ALI R,POLES M,et al. Portal hypertensive gastropathy with a focus on management[J]. Expert Rev Gastroenterol Hepatol,2015,9(9):1207-1216.
|
[33] SONG T,RSSLE M,HE F,et al. Transjugular intrahepatic portosystemic shunt for hepatorenal syndrome:A systematic review and meta-analysis[J]. Dig Liver Dis,2018,50(4):323-330.
|
[34] GRADY K,GOWDA S,KINGAH P,et al. Coil embolization of pulmonary arteries as a palliative treatment of diffuse type I hepatopulmonary syndrome[J]. Respir Care,2015,60(2):e20-e25.
|